Another House committee investigating Vioxx

The House Energy and Commerce Committee announced Tuesday that it is investigating FDA's handling of the withdrawal of Merck's Vioxx rofecoxib. Committee

Read the full 227 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE